We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Topical Patch Provides Dermal Analgesia

By HospiMedica staff writers
Posted on 07 Jul 2006
A new anesthetic patch is designed to prevent pain in patients prior to venous access and dermatologic procedures, and it can be used in children over the age of three.

Synera, manufactured by Endo Pharmaceuticals (Chadds Ford, PA, USA), is a two-step, peel-and-stick topical patch that consists of a thin, uniform, local anesthetic formulation together with an integrated, oxygen-activated heating component intended to enhance the delivery of the anesthetic. More...
The drug formulation is a eutectic mixture of lidocaine 70 mg and tetracaine 70 mg. The recommended application time for the Synera patch is 20 to 30 minutes before the procedure. Synera is the first self-contained topical patch for prevention of pain associated with superficial venous access and superficial dermatologic procedures in patients three years of age and older.

We believe Synera offers patients and caregivers greater utility and convenience over currently available treatments for those who may experience pain with needle sticks, said Peter A. Lankau, president and chief executive officer of Endo Pharmaceuticals.
"Endo is pleased to offer this exciting and innovative therapy to healthcare professionals for their adult and pediatric patients.”

"Pain caused by superficial venous access procedures--such as IV infusions and blood draws--can and should be anticipated and prevented, said Susan T. Verghese, M.D., a pediatric anesthesiologist and professor at the departments of anesthesiology and pediatrics at George Washington University Medical Center (Washington, DC, USA).

Hospitalized children are routinely subjected to multiple superficial venous access procedures such as IV infusions and blood draws.



Related Links:
Endo Pharmaceuticals

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.